AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 126 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $907,644 | -42.7% | 142,264 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $1,585,249 | -24.0% | 142,944 | +5.2% | 0.00% | 0.0% |
| Q1 2023 | $2,086,664 | -31.6% | 135,939 | +0.6% | 0.00% | -50.0% |
| Q4 2022 | $3,051,536 | +100.5% | 135,090 | +47.7% | 0.00% | +100.0% |
| Q3 2022 | $1,521,864 | +15.3% | 91,468 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $1,319,422 | -11.4% | 91,951 | +12.0% | 0.00% | 0.0% |
| Q1 2022 | $1,488,868 | +215.4% | 82,116 | +316.0% | 0.00% | – |
| Q4 2021 | $472,000 | -3.1% | 19,741 | -0.1% | 0.00% | – |
| Q3 2021 | $487,000 | +16.0% | 19,767 | +16.3% | 0.00% | – |
| Q2 2021 | $420,000 | +13.2% | 16,997 | -0.1% | 0.00% | – |
| Q1 2021 | $371,000 | +49.6% | 17,021 | +75.3% | 0.00% | – |
| Q4 2020 | $248,000 | -0.8% | 9,711 | +9.3% | 0.00% | – |
| Q3 2020 | $250,000 | – | 8,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
| COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
| 5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
| RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
| Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
| RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
| Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
| Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
| AtonRa Partners | 18,970 | $121,029 | 0.25% |
| Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |